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Streptomyces is one of the most abundant microbial genera in cave environments. The 
characteristic most notable of Streptomyces is its ability to produce bioactive secondary 
metabolites – such as antifungals, antivirals, antitumorales, anti-hypertensives, 
immunosuppressants, and antibiotics. Through the present research, secondary metabolites 
produced by the cave-dwelling Streptomyces sp. strain ICC1 were examined; a strain which is 
prevalent in the isolated environment of the Iron Curtain Cave in Chilliwack, British Columbia. 
Secondary metabolites secreted by Streptomyces sp. ICC1 have demonstrated antimicrobial 
properties, effective against both multi-drug resistant strains and common laboratory strains of 
Escherichia coli and Staphylococcus aureus. Liquid organic solvent extractions as well as 
preparative and analytical reverse-phase high performance liquid chromatography suggest that 
the bioactive secondary metabolites are polar with hydrophobic substituents. Further instrumental 
analysis is required to determine the antimicrobial active secondary metabolites structure and 























I would like to extend my sincere gratitude to my supervisor Dr. Heidi Huttunen-Hennelly for her 
help even during her absence. To Dr. Naowarat Cheeptham for her continued support, patience, 
understanding, as well as laboratory space and supplies. I would also like to extend thanks toward 
professors and lab technicians who provided me guidance throughout my research. To Dr. Eric 
Bottos for his knowledge on microbiology and problem-solving abilities. To Trent Hammer for 
his assistance in instrumental set up and analysis, particularly with HPLC techniques. To Dr. 
Dipesh Prema and Dr. Kingsley Donkor for their instruction with NMR analysis and valuable 





































Table of Contents…………………………………………………………………………………iv 
 
List of Figures……………………………………………………………………………………...v 
 




 The Iron Curtain Cave……………………………………………………………………. 1 
 
 Genus Streptomyces………………………………………………………………………..3 
 
 Secondary Metabolite Production…………………………………………………………8 
 
Materials and Methods…………………………………………………………………………...12 
 
 Recovery from Dormant Colonies………………………………………………………..12 
 
 Preparations for Escherichia coli #15-124……………………………………………….12 
 Bioassay Screening for Antimicrobial Activity…………………………………………..13 
 Active Compound(s) Separation and Preliminary Structural Analysis…………………..14 
Results……………………………………………………………………………………………16 
 Bioassay for Antimicrobial Activity……………………………………………………...16 
 
 Compound Separation Via Reverse-Phase HPLC……………………………………….17 
 













LIST OF FIGURES 
 
Figure 1. Map of the Iron Curtain Cave in Chilliwack, BC, where Streptomyces sp. ICC1, which 
is the strain of interest, was retrieved from Point 1.……………………………………………….3 
 
Figure 2. The developmental life cycle of Streptomyces from spore to aerial hypha .……………4 
 
Figure 3. Scanning electron micrograph of hyphae and spores of Streptomyces coelicolor………5 
 
Figure 4. Scanning electron micrograph of Streptomyces sp. ICC1……………………………….7 
 
Figure 5. Macroscopic morphology of Streptomyces sp. ICC1 on nutrient agar………………….7 
 
Figure 6. Filtered secondary metabolites produced by Streptomyces sp. ICC1………………….10 
 
Figure 7. Kirby-Bauer disk diffusion test against multi-drug resistant Escherichia coli #15-124 
showing bioactivity after diethyl ether extractions……………………………………………….17 
 
Figure 8. Analytical reverse-phase HPLC chromatograms of bioactive secondary metabolites in 
methanol measured at 272 nm……………………………………………………………………18 
 
Figure 9. Preparative reverse-phase HPLC of bioactive secondary metabolites in methanol……19 
 
Figure 10. Kirby-Bauer disk diffusion test against multi-drug resistant Escherichia coli #15-124 
showing bioactivity on Peak 2 and 4 of preparative HPLC collections………………………….20 
 





LIST OF TABLES 
 
Table 1. Analytical and Preparative HPLC parameters for compound separation………………14 
 
Table 2. NMR parameters for structural elucidation……………………………………………..14 
 








Drug resistance microbes have presented an issue to human healthcare since the first observed 
resistance from a strain of Staphylococcus against penicillin in 1942 (Lobanovska and Pilla 
2017). Since then, the discovery of new antibiotics has been necessary to combat the spread of 
bacteria that are resistant to available pharmaceuticals. Understanding the evolution and origins 
of antibiotic resistance genes is vital to predicting, preventing and managing this global health 
problem.  Studies over the past decade have revealed that antibiotic resistance is common in 
contemporary and ancient environmental bacteria, and that the associated genes are similar or 
identical to those circulating in pathogens (Perry et al. 2014). Most notable was a study 
performed by Bhullar and colleagues (2016) where microbial samples from a region of the 
Lechuguilla Cave in New Mexico, which was thought to have been isolated from surface input 
for over 4 million years, displayed resistance to commercially available antibiotics. While 
resistance is a natural phenomenon, what has changed since the beginning of the antibiotic era is 
a marked increase in selection for mobile resistance elements and consequently, increase of drug 
resistant pathogenic and non-pathogenic bacteria (Pawlowski et al. 2016). According to the 
World Health Organization at least 700,000 individuals die each year due to drug-resistant 
diseases (Sarkar et al. 2017). Therefore, an overwhelming demand for novel treatment presents 
itself; the likelihood of multi-resistant microbes surpassing the development of antibiotics 
escalates in a coevolutionary race between humans and bacteria.  
 
The Iron Curtain Cave 
The Iron Curtain Cave is located near Chilliwack, British Columbia. It was discovered by caver 
Rob Wall in 1993 and named for its iron-rich sediment. The cave is decorated with large curtains 
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made of calcium carbonate and limestone structures. While the sediment contains iron that gives 
it a unique reddish coloration, it also has a clay consistency that indicates higher levels of 
moisture (Ghosh et al. 2017). Studies of unique environments have demonstrated that metals play 
a pivotal role in determining subsurface living communities (Parnell et al. 2015). Iron is one of 
the most abundant metals in the Earth’s crust and is present in various biomolecules (Parnell et 
al. 2015). Iron is essential for the function of many fundamental, conserved biochemical 
processes, such as the electron transport and Krebs cycle (Bonis and Gralnick 2015). Many cave 
bacterial species use iron in a variety of ways, for instance the genus Thiobacillus can obtain 
energy by oxidizing sulfur and ferrous iron compounds (De Mandal et al. 2017). The oxidation 
state of iron also influences soil structure, dissolved carbon stability, and enzyme activity, 
affecting microbial communities and soil fertility (Bonis and Gralnick 2015).  
 
There are six pools of water present from the entrance and throughout the Iron Curtain cave, 
which creates a humid environment. The temperature ranges between 4–12 °C depending on the 
time of year (Ghosh et al. 2017). The cave has been exposed to a limited number of people as it is 
gated and locked, and any access to it needs prior permission from the cave custodian, Rob Wall. 
Within the cave there is a specific path to limit human impact as well as to preserve the features 
and habitat of the cave. The microbe of importance in this study, Streptomyces sp. ICC1, was 
originally isolate 22.47 m from the entrance of the cave, depicted as point 1 in Figure 1 illustrated 
by Ghosh et al. (2017). The unique conditions of the Iron Curtain Cave – including high 
humidity, relatively low but stable temperatures, and low nutrients, create a highly selective 
environment. Energy-starved conditions of caves often lead to the production of various 
secondary metabolites that enhance their producers’ likelihood of survival (Gosse et al. 2019). 
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Streptomyces sp. ICC1 is able to thrive in such desolate conditions due to their unique physiology 
and specialized metabolic pathways.  
 
Figure 1. Map of the Iron Curtain Cave in Chilliwack, BC, where Streptomyces sp. ICC1, 
which is the strain of interest, was retrieved from Point 1 (Ghost et al. 2017). 
 
 
Genus Streptomyces  
Streptomyces is a genus of the family Streptomycetaceae belonging to the order 
Actinomycetales and the class Schizomycetes. Streptomyces are Gram-positive bacteria that have 
a DNA GC content of 69–78 mol% (Korn-Wendisch & Kutzner, 1992). This genus grows 
predominately in soil but is also found in various other locations including marine environments 
and caves (Flärdh and Buttner 2009). The morphology of most soil dwelling Streptomyces 
resembles filamentous fungi due to the production of an extensive branching substrate and aerial 
mycelia. The substrate hyphae are approximately 0.5 to 1.0 µm in diameter and often lack cross-
walls during the vegetative phase (Anderson and Wellingtonn 2001). Growth occurs at the hyphal 
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apices and is accompanied by branching, thus producing a complex tightly woven matrix of 
hyphae during the vegetative growth phase. As the colony ages, aerial mycelia are produced, 
which develop into chains of spores by the formation of cross walls in the multinucleate aerial 
filaments. This is followed by separation of individual cells directly into spores. The 
morphological features of aerial mycelium are regarded as more significant for characterization 
than vegetative mycelium. The aerial mycelium include the mode of branching, the configuration 
of the spore chains, and the surface of the spores. 
 
Figure 2. The developmental life cycle of Streptomyces from spore to aerial hypha (Flärdh 




Figure 3. Scanning electron micrograph of hyphae and spores of Streptomyces coelicolor 
(Tschowri 2015). 
 
The spores in soil germinate to produce mycelium under favorable conditions. Upon germination, 
the cells show complex vegetative hyphal growth, which aids the microbes’ ability to colonize 
the soil. Under conditions of high concentration of nutrient and energy sources, the hyphae are 
highly branched and excrete a number of extracellular enzymes in order to obtain the required 
nutrients for growth (Avignone-Rossa et al. 2013). In contrast, conditions of nutrient scarcity 
restrict cell growth and aerial mycelium is formed, eventually differentiating into spores and 
therefore restarting the cycle. This morphological change is accompanied by metabolic changes, 
which result in the induction of secondary metabolism. The formation of spores, a semi-dormant 
stage in the life cycle of the bacterium, serves the double purpose of resisting unfavorable 
environments and spreading the organism. Cave dwelling actinomycetes, such as Streptomyces, 
have been studied less compared to soil strains.  
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The strain of interest in the present study is Streptomyces sp. ICC1, which was collected from the 
Iron Curtain Cave in Chilliwack, British Columbia. Preliminary 16S rRNA gene sequencing of 
ICC1 confirmed that the microbe belongs to the genus Streptomyces, which is supported by 
morphology and growth characteristics of the bacteria (Gosse et al. 2018). The scanning electron 
micrograph captured by Ghosh et al. (2017) shown below as Figure 2 demonstrates that 
Streptomyces ICC1 shares the general trends displayed across the genus, with its dense rode-
shaped filaments and colonial appearance. Whole genome sequencing of Streptomyces sp. ICC1 
by Illumina MiSeq (Illumina, United States) with de novo genome assembly using PATRIC 
generated a draft genome of 9,034,309 nucleotide base pairs containing a guanine and cytosine 
content of 72%. BLAST was used to compare the genomic profile of Streptomyces sp. ICC1 with 
other genomes on the database. The closest genome match was Streptomyces lavendulae strain 
CCM 3239 with 54% sequence alignment to Streptomyces sp. ICC1 and an average nucleotide 
identity of 87.9% between the organisms. (Gosse et al. 2018). In addition, RAST annotation 
predicted 8235 coding regions for Streptomyces sp. ICC1, which indicates very similar predicted 
protein content and function between the strain of interest and S. lavendulae (Gosse et al. 2018). 
While Streptomyces lavendulae was found to have the closest genomic match to Streptomyces sp. 
ICC1, due to a low percent similarity of 87.9% it remains undetermined if they are the same 
species. Current research regarding different strains Streptomyces lavendulae is being performed 
by Dr. Christopher Boddy at the University of Ottawa in the Department of Chemistry and 
Biomolecular sciences. Dr. Boddy was involved in the whole genomic sequencing and 
metabolomic study of Streptomyces sp. ICC1 as well as another bacterium originally isolated 




Figure 4. Scanning electron micrograph of Streptomyces sp. ICC1 showing a dense mass of 
interwoven filaments with irregular rugose surface collected from the Iron Curtain Cave 




Figure 5. Macroscopic morphology of Streptomyces sp. ICC1 on nutrient agar after fourteen 








Secondary Metabolite Production 
 
A large variety of compounds are produced by microorganisms through means of specialized 
biosynthetic pathways. Secondary metabolites are low-molecular-mass organic compounds that, 
unlike primary metabolites, are not directly involved in the growth, development, or reproduction 
of the producing organisms. The small diffusible molecules disperse from the microorganism and 
may provide its producer an advantage by adapting to the extracellular conditions to some degree 
(Cihak et al. 2017). They may also aid in defense, competition, signaling, or interspecies 
interactions, depending on the environmental cues, thus increasing the likelihood of survival in 
an inhospitable environment. In natural conditions, secondary metabolites are primarily present at 
low concentrations (Netzker et al. 2015). Secondary metabolites may also play a role in 
transferring information between cells. Secondary metabolites create signaling networks that aid 
in intra‐ and inter‐species communication, as well as in regulation of many aspects of 
metabolism, virulence, physiology, competence, motility, symbiosis, and other functions (Dufour 
and Roa 2011). Chemical communication occurs between bacteria-bacteria or bacteria-fungi 
since they form close communities in nature. Successful co-existence can be mediated through 
these signaling molecules in low concentration where the fungal mycelia and bacterial filaments 
of both microorganisms are connected together (Abdalla et al. 2017). For instance, α-
Butyrolactone is present in most Streptomyces and was the first Streptomyces sporulation factor 
discovered. α-butyrolactones are analogous to homoserine lactones and have been deduced to 
play an important role as signals as well as markers for the setting-in of morphological and 
physiological differentiation (Safari et al. 2014). It was first characterized as an activator of 





An interesting property of Streptomyces is its ability to produce bioactive secondary metabolites, 
such as antifungals, antivirals, antitumorals, anti-hypertensives, immunosuppressants, and 
antibiotics (Procópio et al. 2012). Streptomyces are regarded as the most prolific source of 
bioactive compounds in particular commercially available antibiotics since they produce 
approximately two-thirds of commercially available antibiotics (Barka et al. 2016). The 
production of most antibiotics is species specific, and these secondary metabolites are important 
for Streptomyces species in order to compete with other microorganisms that come in contact, 
even within the same genus. The bioactivity of the small molecules is mostly achieved by 
affecting transcription in receiving cells. The genes for the biosynthesis of Streptomyces 
secondary metabolites are mostly clustered and their expression is highly regulated (Tanaka et al. 
2013). The biosynthetic genes of most secondary metabolites have previously been shown to be 
expressed during germination (Strakova et al. 2013). Secondary metabolite production 
predominately occurs at the aerial hyphae developmental stage and are isolated during stationary 
phase of growth in liquid cultures (Seipke et al. 2012). The setoff of those physiological states, 
and therefore of the associated synthesis of secondary metabolites, is linked to the depletion of 
nutrients. A decrease in growth rate may be the signal for triggering secondary metabolism.   
 
The secondary metabolites produced by Streptomyces often have dark pigmentation due to the 
synthesis and excretion of melanins or melanoid pigments. Melanin compounds are irregular, 
dark brown polymers that are hydrophobic and negatively charged. Various microorganisms 
produce melanins through fermentative oxidation or oxidative polymerization of phenolic or 
indolic compounds. These compounds play important roles in microorganisms against thermal, 
chemical, and biochemical stresses. Specifically, melanins have radioprotective and antioxidant 
properties that can effectively protect the living organisms from ultraviolet radiation, heavy 
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metals, and oxidizing agents (Nagger and Ewasy 2017). In addition, the melanin synthesized by 
microbes help maintain their water and ion storage through increasing the structural rigidity of 
their cell wall (Allam and Zaher 2012).  
 
Figure 6. Brown pigmentation characteristic of Streptomyces sp. ICC1 secondary 
metabolites grown in nutrient broth for nine days at 15°C.  
 
In the present study secondary metabolites produced by Streptomyces sp. strain ICC1 have been 
examined. Secondary metabolites secreted by Streptomyces sp. ICC1 have shown antimicrobial 
properties, effective against both multi-drug resistant strains and common laboratory strains 
of Escherichia coli and Staphylococcus aureus. The bioactive secondary metabolites produced 
by Streptomyces sp. ICC1 strain were separated out from culture via diethyl ether liquid-phase 
organic solvent and water extractions. The metabolite containing solution was purified and 
separated via analytical and preparative reversed-phase high performance liquid 
chromatography (HPLC) techniques. Each peak from the HPLC was tested for antimicrobial 
activity through disk diffusion and well assay methods. One-dimensional proton nuclear 
magnetic resonance (NMR) spectroscopy was used in attempt to elucidate the structure of each 
active fraction that was identified by HPLC. Organic extractions with diethyl ether suggest the 
11 
 
bioactive compounds are polar but also contain hydrophobic substituents due to how the activity 
stays within the less polar organic layer relative to water. In addition, the reverse-phase HPLC 
results suggest that the secondary metabolites are polar due to short retention times with the 
elution of a polar mobile phase. Together, the findings of the present study indicate that the 
secondary metabolites secreted by Streptomyces sp. ICC1 are polar and with some hydrophobic 
substituents. Future work to further the understanding of the bioactive compounds involve 
additional instrumentation techniques, such as carbon-13 NMR spectroscopy and mass 
spectrometry, as well as comparisons to secondary metabolites produced by other members of 






























MATERIALS AND METHODS 
 
Storage and Growth of Streptomyces sp. ICC1 
 
Dormant cells of Streptomyces sp. ICC1 strain were stored in glycerol stock at -80°C. For 
recovery, a sterile loop was used to scrape material from the top of the frozen stock and streaked, 
in triplicate, onto nutrient agar plates. The plates were incubated at 15°C for growth and 
secondary metabolite production. Visible colonies were present after seven days of incubation 
and were irregular shaped, dry texture, rugose surface, and opaque cream in color.  For liquid 
cultures, 150 mL of nutrient broth was inoculated with a single colony of Streptomyces sp. ICC1, 
followed by incubation in a shaker incubator at 150 rpm and 15°C for 5 to 40 days. Plates were 
sealed with parafilmed and kept at 4°C until fresh stocks were made.  
 
Growth of Escherichia coli #15-124 
Multi-drug resistant Escherichia coli #15-124 was prepared with antibiotic mixed into the 
nutrient agar in order to prevent mutations that decreased resistance. A stock solution of 
chloramphenicol was produced by weighing 0.8078g into 5 mL of ethanol for a final 
concentration of 0.05 M. From this stock solution, 100 µL was added to 100 mL of molten 
nutrient agar for a final concentration of 50 µM. The nutrient agar was poured into four petri 
dishes and allowed to solidify before thawed freezer stock of multi-drug resistant Escherichia 
coli #15-124 was four-way streaked. The plates were incubated at 37°C for 24 h prior to storing 
in a 4°C fridge. 
 
Bioassay Screening for Antimicrobial Activity 
Target organisms were cultured overnight at 37°C to 0.60-0.90 OD600 to suggest active 
logarithmic division was occurring. The target organisms used include Escherichia coli #15-124, 
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Escherichia coli #59, laboratory Staphylococcus aureus, and methicillin-resistant Staphylococcus 
aureus ATCC-43300. 
 
A 10ml aliquot of the Streptomyces sp. ICC1 broth culture was retrieved from 15°C incubator 
after 5-40 days at 150 rpm. Brown pigmentation was apparent after 5 days of incubation with 
bioactivity occurring at this time or anywhere up to 40 days after. The sample was centrifuged at 
10,000 rpm for 20 minutes. The supernatant was collected and filtered through a sterile 
hydrophilic low-protein-binding polyether sulfone membrane syringe filter with 0.22 μm pore 
size. The filtered supernatant contained the Streptomyces sp. ICC1 secondary metabolites. Liquid 
extractions were performed with filtrate aliquots of 1:1 broth to diethyl ether by mixing them in a 
separatory funnel for one minute with frequent pauses for ventilation.  
 
Kirby-Bauer disk diffusion assays were used to determine whether a sample had antimicrobial 
activity by the presence or absence of a zone of inhibition around a solution infused disk. 
Bioassay screening was performed in 15 mm x 150 mm polystyrene Petri dishes. Eighty mL of 
autoclaved molten nutrient agar was inoculated with a ratio of 1% volume to volume of the 
exponentially dividing target organism, OD600 between 0.600-0.900. Autoclaved 6 mm paper 
disks (Toyo, Advantech) were saturated with filtered broth, diethyl ether, post-extraction aqueous 
filtrate or organic diethyl ether layer and dried completely prior to addition to the bioassay plate. 
For the Kirby-Bauer disk diffusion method, disks containing different controls and experimental 
conditions were evenly placed onto nutrient agar that had been inoculated with a target organism. 
Antimicrobial activity was determined by whether the target organism was able to grow around 
the disk. The Kirby-Bauer disk diffusion method was supplemented with Well-assays to 
determine antimicrobial activity. For the Well-assay technique, Pasteur pipettes were used to 
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make wells in the molten agar. The depth of the wells were approximately midway between the 
bottom of the top and bottom of the agar, 100 µl of filtered secondary metabolite broth as well as 
controls was pipetted into the wells.  
 
Diethyl ether was used as a control to ensure diethyl ether did not inhibit the growth of the 
bacteria lawn. In addition, a disk containing10 µg of ampicillin was used to confirm that the 
target bacteria were resistant to common pharmaceuticals such as ampicillin.  All bioassay 
screening was performed within a biosafety cabinet to reduce contamination. Five minutes of 
ultraviolet radiation was used to sterilize glassware, picks, loops, and plastic equipment prior to 
use. The bioassay plates were incubated at 37°C for 24 h to ensure optimal growth of the target 
bacterial lawn. The diameter or absence of zones of inhibition were recorded for each 
experimental condition.  
 
Active Compound(s) Separation and Preliminary Structural Analysis 
The organic layer of the diethyl ether extraction was known to possess antimicrobial activity 
against the previously mentioned target organisms based on the bioassays performed. Liquid 
extractions with diethyl ether were performed on aliquots of the Streptomyces sp. ICC1 broth 
culture collected between 5 and 40 days of incubation at 15°C at 150 rpm. One portion of broth 
culture was extracted with equal portions of diethyl ether three times. The organic layers from 
each extraction performed on the same day, which were one third of the total extraction volume, 
were combined and evaporated. Extracts were dissolved from the dry flasks in 10 mL of HPLC-
grade methanol and 2 mL of water prior to injection into the Agilent 1220 Infinity II high 
performance liquid chromatography (HPLC) system. Separation was performed according to the 
analytical reversed-phase HPLC conditions summarized in Table 1. Following method 
15 
 
development, individual fractions were collected via the preparative HPLC conditions listed in 
Table 1. The resulting four separated components were divided among Eppendorf tubes and the 
eluent evaporated on a Vacufuge® 5301 Centrifugal Vacuum Concentrator at 45°C. One sample 
from each separation was resuspended in deionized 18MOhm water and analyzed for 
antimicrobial activity via Kirby Bauer disk diffusion assays. Remaining samples were 
resuspended in deuterium oxide for structural elucidation with one-dimensional proton nuclear 
magnetic resonance (NMR) spectroscopy via a 500 MHz Bruker Avance AMIII 500 
Spectrometer. 
 
Table 1. Analytical and preparative HPLC parameters for compound separation. 
 Analytical HPLC Parameters Preparative HPLC Parameters 
Instrument Agilent 1220 Infinity HPLC Waters HPLC 486 
Column Kinetex® 2.6 μm EVO C18 
100Ȧ 
Phenomenex® Jupiter 10µ C18 
300Ȧ 
Dimensions  100 x 3.0 mm 250 x 21.20 mm 
Detector 272 nm 272 nm 
Flow Rate 0.4 mL/min 5 mL/min 
Injection Volume 5.0 μL 1.0 mL 
Eluent A: 5 mM NH4OAc in 18 MOhm H2O 
B: Acetonitrile 
 
Program Gradient 1-21 min 90% A 10% B 
21-35 min 100% B 
35-47 min 90% A 10% B 
 
Table 2. NMR parameters for structural elucidation. 
 
Instrument Bruker Avance AMIII 500 Spectrometer 
Operating Frequency 500 MHz 
Solvent D2O 











Bioassay for Antimicrobial Activity 
 
Well assays and Kirby-Bauer disk diffusion assays were performed on nutrient agar with all 
target organisms listed. Zones of inhibition occurred 5 days post-inoculation and decreased in 
diameter when samples were incubated for longer durations. Zones of inhibition ranged from 8 to 
6.5 mm in diameter for the organic layer after diethyl ether extraction and filtered broth culture. 
After antimicrobial activity was confirmed, liquid organic solvent extractions were performed to 
elucidate the relative polarity of the bioactive antimicrobial secondary metabolites. Extractions 
were performed with diethyl ether, which was previously shown by Alysha Milward (2019) to be 
the most successful organic solvent compared to ethyl acetate, hexane, and 1-octanol. Solvent 
success was determined by the antimicrobial activity being maintained in either the aqueous or 
organic layer post extraction. Solvents were deemed unsuccessful if bioactivity against the target 
organism was either inconsistently observed or absence. As depicted in Figure 7, activity was 
present in the organic layer of the extraction as well as filtered broth when all conditions 
including diethyl ether control, ampicillin control, and aqueous layer of the extraction were tested 
using a Kirby-Bauer disk diffusion assay. Also, it should be noted that bioactivity was 
inconsistent throughout the present research, for example the same culture would be sporadically 
successful and unsuccessful against the same target bacteria at different points of incubation. 
Furthermore, some liquid cultures produced from the same plate of Streptomyces sp. ICC1 would 




Figure 7. Kirby-Bauer disk diffusion test for Streptomyces sp. ICC1 secondary metabolites 
against multi-drug resistant Escherichia coli #15-124 showing bioactivity in the organic 
layer after diethyl ether extractions. 
 
 
Compound Separation via Reverse-Phase HPLC 
In order to begin separating compounds in the diethyl ether extract from Streptomyces sp. ICC1, 
reverse-phase HPLC was used to produce fractions of the sample based on differing polarities. 
The program gradient for both the analytical and preparative reverse-phase HPLC was as follows: 
during the first 21 minutes the initial 90:10 ammonium acetate buffer to acetonitrile ratio moved 
to 100% acetonitrile, which remained at 100% between 21 to 35 minutes, after 35 minutes the 
program gradient transitioned slowly back to 90:10 buffer to acetonitrile ratio that occurred at 47 
minutes.  Absorbance was measured at 272nm for reverse-phase HPLC techniques since this 
wavelength was previously found by Alysha Milward (2019) to provide a chromatogram with a 
stronger baseline and sharper peaks. Analytical revers-phase HPLC was used for method 
development to estimate when the sample eluted and provide information regarding how long the 
preparative reverse-phase HPLC should be run for. Blank runs with water were first run to 
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determine baseline activity. Figure 8 shows the chromatogram from the bioactive secondary 
metabolites resuspended in methanol. The majority of the sample eluted quickly from the column 
while the rest eluted at 38.434 minutes when the program gradient returned to a 90:10 buffer to 




Figure 8. Analytical reverse-phase HPLC chromatograms of bioactive secondary 
metabolites in methanol measured at 272 nm.  
 
 
The preparative reversed-phase HPLC chromatogram, shown below in Figure 9, had different 
absorbance readings and separation from that of the analytical chromatogram as a result of the 
different column volumes. The Phenomenex® Jupiter 10u C18 column has a non-polar stationary 
phase, therefore polar substituents are the first to elute due to their high affinity for the polar 
mobile phase. Five runs were performed on the same culture sample to ensure the results were 
repeatable. Fractions covered a broad range of materials Fraction 1 was a broad short peak, which 
had a retention time between 8 to 10 minutes in each of the five trials run. Fraction 2 was the 
tallest peak of the four observed and had a consistent height between samples. The trail of peaks 
following Fraction 2 were denoted Fraction 3 since the number and height of each peak within 
this cluster varied between runs. Fraction 4 was a relatively small peak that occurred 
approximately at 42 minutes after injection. Due to the high-volume capacity of the preparative 
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Phenomenex® Jupiter 10u C18 column, it can be reasoned that all of the fractions collected were 
likely eluted in 90% 5 mM ammonium acetate buffer and 10% acetonitrile. 
 
 
Figure 9. Preparative reverse-phase HPLC of bioactive secondary metabolites in methanol.  
 
The four fractions were evaporated to remove all the remaining HPLC solvent, which left a 
brown pigmented solid residue in the collection tubes. Following eluent evaporation, the 
bioactivity of each of the four factions collected, which were dissolved in methanol, were tested 
via Kirby-Bauer disk diffusion assays. As shown below in Figure 10, the bioactive secondary 
metabolites were separated into Fraction 2 and Fraction 4 using the preparative reversed-phase 
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HPLC conditions used. The clear zones of inhibition against the multi-drug resistant strain 
Escherichia coli #15-124 are indicative of antimicrobial agents having been absorbed into the 
applied paper disk. Fraction 2 was further analyzed for structural elucidation via one-dimensional 
1H NMR analysis. Whereas Fraction 4 did not produce enough sample to be effectively used for 
1-D 1H NMR analysis. 
 
Figure 10. Kirby-Bauer disk diffusion test against multi-drug resistant Escherichia coli #15-
124 showing bioactivity on Peak 2 and 4 of preparative HPLC collections.  
 
 
Structural Elucidation of Bioactive HPLC Collections by 1-D 1H-NMR 
 
The spectrum obtained from analyzing Fraction 2 in D2O at 1024 scans by the 500 MHz Bruker 
NMR spectrometer can be seen below in Figure 11. Chloroform was initially used in attempt to 
dissolve solid Fraction 2 after evaporation; however, this solvent was ineffective so D2O was 
used to dissolve the Fraction for the remaining trials. The large singlet at 4.75ppm was the 
solvent residual peak of D2O. The signal peak at 2.0 ppm was likely acetonitrile residue, which 
was used in preparative HPLC. The peaks present at 0.8 and 1.2 ppm are likely grease carried 
over from greasing the joints of the evaporation apparatus. The following interpretations of the 
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various splitting observed in Figure 11 should be confirmed by running 1-D1H NMR 
spectroscopy with a larger quantity of sample. The singlet at approximately 3.20 ppm may 
correspond to a tert-butyl methyl ether group due to its position in the spectrum. Additionally, the 
complicated splitting observed in the peaks appearing following the OCH3 from 3.5-4.0 ppm may 
be a result of protons being nearby electron-withdrawing groups, such as alkenes, or 
electronegative oxygen or nitrogen atoms. The quadruplet at approximately 4.2 ppm is possibly 
an ethyl proton adjacent to a methyl group due to its’ relatively deshielded position. Also 
apparent on the spectra are a quadruplet and triplet at 1.35 ppm and 4.30 ppm, respectively. No 
peaks were observed downfield of the D2O singlet at 4.75 ppm. The sample did not appear to 
decompose after being left in a 4 ⁰C refrigerator for 48 hours in D2O since the sample run for 128 
scans the first day showed the same distinctive peaks after being run for 1024 scans two days 
later. A larger number of scans was used to produce sharper peaks that were more easily 





Figure 11. A) 1-D1 H NMR spectra of Peak 2 dissolved in deuterium oxide, NS=1024. B) 







Through antimicrobial assays, the secondary metabolites produce by Streptomyces sp. ICC1 have 
been notably effective against Gram-negative and Gram-positive target bacterium, namely 
laboratory and multi-drug resistant strains of Escherichia coli and Staphylococcus aureus. The 
antimicrobial activity demonstrated by Streptomyces sp. ICC1 is comparable to other members of 
the Streptomyces genus, which are among the most numerous and most versatile soil 
microorganisms. The genus Streptomyces is characterized by their large metabolite production 
rate, biotransformation processes, capability of degrading lignocellulose and chitin, and their 
fundamental role in biological cycles of organic matter (Procopio et al. 2012). The genome of S. 
coelicolor, for example, encodes many secreted proteins, including 60 proteases, 13 
chitinases/chitosanases, eight cellulases/endoglucanases, three amylases, and two pactato lyases 
(Procopio et al. 2012). In addition, the results relate to other cave studies for instance Turkish 
karstic caves were reported to harbor Actinobacteria, for which over half of the isolates, were 
active against several microbial pathogens including Gram positive bacteria, Gram negative 
bacteria, yeast, and filamentous fungi (Yücel and Yamac 2010). One of the Actinobacteria, 
Streptomyces sp. 1492, had strong activity against clinical strains of MRSA, VRE, 
and Acinetobacter baumannii. Furthermore, Streptomyces E9 isolated from Helmcken Falls cave 
in British Columbia could inhibit the growth of Paenibacillus larvae, a causative agent of 
American foulbrood disease in honeybees (Kay et al. 2013). The bioactive compounds examined 
in this research should be tested against additional infectious microbes to determine their 




Following liquid organic extractions with the aqueous metabolite-containing broth culture, 
bioactivity was present with in the organic, less polar layer of the diethyl ether-water extraction. 
Diethyl ether has a bent molecular structure that produces a small dipole moment, this property of 
diethyl ether allows the essentially polar liquid to be used to isolate both non-polar and polar 
compounds in aqueous extractions. The secondary metabolites were maintained in the organic 
layer following extractions, which suggests that the compounds are polar and may contain 
hydrophobic functional groups.  
 
Analytical and preparative reversed-phase high performance liquid chromatography analysis 
revealed mainly polar Fractions within the diethyl ether extracts.  The compounds within 
Fractions 1, 2 and 3 likely possess more of a hydrophilic, polar nature due to how they eluted 
when the program gradient contained ammonium acetate in the polar mobile phase. Ammonium 
acetate buffer is more polar relative to acetonitrile, which means compounds that eluted during 
this program gradient were polar since they were able to elute in the more polar mobile phase 
compared to 100% acetonitrile. Fraction 4 eluted once the program gradient returned to a 90:10 
ammonium acetate buffer to acetonitrile ratio. It can be inferred that Fraction 4 was less polar 
since it adhered to the column until the mobile phase returned to a polarity it was able to dissolve 
in. From additional Kirby-Bauer disk diffusion assays, it was determined that the antimicrobial 
secondary metabolites from Streptomyces sp. ICC1 were separated into Peaks 2 and 4. It unclear 
whether these peaks contain entirely different bioactive compounds or if there was carry-over 
from the high-volume capacity of the preparative Phenomenex® Jupiter C18 column. The 
chromatogram suggests there may be incomplete chromatographic separation due to the close 
proximity of the Fractions observed. A longer program gradient at a higher aqueous 
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concentration could potentially establish whether these peaks possess different bioactive 
molecules.   
 
1-D1H NMR spectroscopy should be repeated with higher concentrations of the analyzed sample. 
Further analysis may intensify present peaks or reveal additional peaks, such as the 
highly deshielded signals found in past work by Alysha Milward (2019). The 1-D1H NMR 
spectrum demonstrates insufficient sample may have been used due to the small size of sample 
peaks compared to solvent residual peaks. The high level of splitting and peaks present could 
suggest that the Streptomyces sp. ICC1 bioactive compounds are complex, however they are 
unlikely proteinaceous in nature due to the absence of amine groups on the spectrum. The 1-D1H 
NMR spectrum also provides supports that the bioactive compounds are polar with hydrophobic 
substituents due to the hydrophobic functional groups, which contain hydrogen atoms, illustrated 
in the spectrum. In future work sodium phosphate should be added to the deuterium oxide to 
mimic physiological conditions.  
 
Comparing the compounds produced by Streptomyces sp. ICC1 to those synthesized by 
streptomyces from the literature does not offer much insight since they exhibit extreme chemical 
diversity. The compounds range from simple amino acid derivatives to high molecular weight 
proteins, and macro lactones from simple eight membered lactones to different condensed macro 
lactones (Harir et al. 2018). For example, actinomycin was first isolated from Streptomyces 
antibioticus and is produced by many Streptomyces strains. The actinomycins are a family of 
bicyclic chromopeptide lactones sharing the chromophoric phenoxazinone dicarboxylic acid to 
which are attached two pentapeptide lactones of nonribosomal origin (Singh et al. 
2020). Actinomycin D acts as a transcription inhibitor, binding to DNA duplexes at 
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the transcription initiation complex and preventing RNA polymerase elongation (Koba and 
Konopa 2005).  
 
Throughout the present research bioactivity was lost in the secondary metabolite solution, further 
analyses are required to understand the loss of activity. The inability to inhibit the target bacteria 
may be due to Streptomyces sp. ICC1 mutation during growth in the 15 ⁰C incubator, 
contaminants being present, or the bioactive compounds not being excreted in sufficient 
concentrations. In addition, after centrifuging the Streptomyces sp. ICC1 nutrient broth solution, 
the pellet could contain the bioactive compounds due to adherence to the bacteria cell walls. The 
pellet was discarded after centrifugation and was not tested for antimicrobial activity.  
 
CONCLUSIONS AND FUTURE WORK 
The progression of antibiotic-resistant microorganisms has hindered the therapeutic efficiency of 
various commercially available pharmaceuticals. Therefore, an overwhelming demand for novel 
treatment presents itself as the likelihood of multi-resistant microbes surpassing the development 
of antibiotics escalates in a coevolutionary race between humans and bacteria. Extreme 
environments are starting to be considered as valuable sources of microbial capability, 
particularly in the production of pharmaceutically significant metabolites (Rangseekaew and 
Pathom-aree 2019). The findings of the present study aids in furthering knowledge regarding 
bioactive compounds produced by cave dwelling microbes.  
 
Laboratory growth conditions should be optimized for Streptomyces sp. ICC1. Previous research 
performed by Alysha Milward (2019) found the cave-dwelling strain produced the largest amount 
of bioactive secondary metabolites when grown in 15 mL of nutrient broth compared to Hickey 
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Tesner broth and Reasoner’s 2A broth. However, other media should be examined since media 
used for the isolation of cave actinobacteria range from routine cultivation media such as 
International Streptomyces Project medium 2 (yeast malt extract agar, ISP2) or tryptic soy agar 
(TSA) to selective media including humic acid vitamin agar (HV), starch casein agar (SC), starch 
casein nitrate agar (SCN), peptone-yeast extract/brain-heart infusion medium (PY-BHI), R2A 
medium, actinomycete isolation agar (AI), and Gauze's medium No.1 (Rangseekaew and 
Pathom-aree 2019). Moreover, isolation media that mimic the conditions of low concentration 
nutrients in caves such as tap water agar, 1/100 ISP2 and oligotrophic medium (M5) were also 
successfully used for the isolation of actinobacteria. (Lee et al., 2000b; Velikonja et al., 
2014; Covington et al., 2018; Passari et al., 2018). High concentration of nutrients in standard 
cultivation media were reported to cause cell death in cave-associated bacteria due to osmotic 
stress (Ghosh et al. 2017). 
 
In addition, optimization for the seed should be determined. The seed refers to stock cultures 
from which samples are taken and move into another media for selection of the stationary phase 
of the growth cycle and production of secondary metabolites. Optimal growth conditions likely 
differ to maintain the culture at logistic versus stationary growth phase. The optimal pH, 
temperature and oxygen content should also be established for Streptomyces sp. ICC1. Pervious 
work performed by Alysha Milward (2019) examined the bioactive present after incubation in 8 
⁰C, 15 ⁰C, and 37 ⁰C. A temperature of 15⁰C was found to be most effective at promoting the 
production of secondary metabolites as determined by larger diameters of zones of inhibition 
against target bacteria compared to the other temperatures. However, the Iron Curtain Cave 
ranges between 4–12 °C depending on the time of year, which suggests a larger variety of 
temperatures should be tested to determine the optimal growth conditions for Streptomyces sp. 
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ICC1 (Ghosh et al. 2017).  Streptomycetes are regarded to prefer neutral to alkaline 
environmental pH, the optimal growth pH range being 6.5–8.0 (Kutzner 1986; Locci 1989). 
However, acidophilic and alkalophilic streptomycetes have also been found, such as those 
causing potato scabies have represented phylogenetically diverse group, and included alkalophilic 
strains (Kutzner 1986; Takeuchi et al. 1996). Among streptomycetes common habitats, soil and 
hay have a low mean pH of 3.5–6.8 and pH of 5.5–6.5, respectively (Kutzner 1986; 
Erviöet al. 1990). In buildings suffering water damage and mould growth, pH varies from acid 
and neutral values of building materials to highly basic pH of concrete 
(Nevalainen et al. 1991; Andersson et al. 1998; Kontro et al. 2005).   
 
The methodology practiced should be repeated to produce greater quantities of bioactive 
compounds to validate and ensure the repeatable of the results found here. Future instrumental 
analyses should be executed on the purified samples, primarily 13C NMR and mass spectrometry, 
to elucidate the bioactive molecular structure of the compounds. Additionally, the minimum 
inhibitory concentration of the produced bioactive molecules should be established and 
investigated against several target strains, both Gram-positive and Gram-negative. Further 
bioactive screening on the pellet of the centrifuged product could explain the lost bioactivity. The 
findings should be compared to commercially available secondary metabolites produced by the 
Streptomyces genus to assess the efficiency of a cave-dwelling strain to the more common soil 
species. Further analyses should be performed on the secondary metabolites secreted by cave 
dwelling Streptomyces sp. ICC1 to determine its potential as an antibiotic producing organism for 
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Table A1. The diameters of zones of inhibition =from Kirby-Bauer disk diffusion assays 
using Streptomyces sp. ICC1 broth culture before and after diethyl ether extraction, with E. 
coli #15-124 as the target organism.  
 
Experimental Condition Incubation time (days) Diameter (mm) 
Filtered broth  7 7.0 mm 
Filtered broth 7 6.5 mm 
Filtered broth 10 6.9 mm 
Filtered broth 10 7.0 mm 
Filtered broth 10 6.6 mm 
Filtered broth 15 6.6 mm 
Organic layer  15 6.8 mm 
Organic layer 15 6.8 mm 
Filtered broth 21 6.6 mm 
Filtered broth 21 6.6 mm 
Filtered broth 23 6.7 mm 
Organic layer 23 6.5 mm 
Organic layer 23 6.6 mm 
Peak 2 40 + 8.0 mm 
Peak 4 40+ 7.8 mm 
 
 
 
 
